The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Kite/Gilead; Kyowa Kirin; Novartis; Roche; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Kite/Gilead; Kyowa Kirin; Novartis; Roche; Takeda
Speakers' Bureau - Janssen
Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.
 
Emanuele Zucca
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb; Curis; Incyte; Ipsen; Janssen; Lilly O.; Merck; Miltenyi Biomedicine; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Celgene/Bristol-Myers Squibb (Inst); Incyte (Inst); Janssen (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BeiGene; Janssen; Roche
 
Andrew Davies
Honoraria - AstraZeneca; Bristol-Myers Squibb; Incyte; Kite/Gilead; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Incyte; Kite/Gilead; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); CellCentric (Inst); Gilead Sciences (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Irina Kryachok
Consulting or Advisory Role - Abbvie; Roche; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Janssen; Roche; Sandoz; Takeda
Research Funding - Bayer (Inst); Dr. Reddy's Laboratories (Inst); LabCorp (Inst); Merck (Inst)
Expert Testimony - Abbvie; Roche; Takeda
Travel, Accommodations, Expenses - Sandoz
 
Giovannino Ciccone
No Relationships to Disclose
 
Luca Ceriani
No Relationships to Disclose
 
Barbara Botto
Consulting or Advisory Role - Novartis; Takeda
 
N. George Mikhaeel
No Relationships to Disclose
 
Anna Dabrowska-Iwanicka
Honoraria - Janssen
Consulting or Advisory Role - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Weili Zhao
No Relationships to Disclose
 
Codruta Inescu
No Relationships to Disclose
 
Andrea Janikova
Consulting or Advisory Role - Gilead Sciences; Roche; Takeda
Travel, Accommodations, Expenses - Roche
 
Alexander Fossa
No Relationships to Disclose
 
David Hodgson
No Relationships to Disclose
 
Mats Jerkeman
Honoraria - Abbvie; AstraZeneca; Autolus; Gilead Sciences; Janssen; Pierre Fabre; Roche
Consulting or Advisory Role - Janssen
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Gilead Sciences (Inst); Janssen (Inst); Roche (Inst)
Expert Testimony - Novartis
 
Monica Balzarotti
Honoraria - Gilead Sciences; Incyte; Kyowa Kirin; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Incyte; Janssen; Roche; Takeda
Speakers' Bureau - Gilead Sciences; Incyte; Roche
Research Funding - Roche (Inst)
 
Alessandra Tucci
Honoraria - Kyowa Kirin International; MDS Foundation
Consulting or Advisory Role - Gentili; Janssen; Sanofi; Takeda
Travel, Accommodations, Expenses - sandoz
 
Umberto Ricardi
Honoraria - AstraZeneca
Speakers' Bureau - AstraZeneca
Research Funding - Brainlab (Inst)
 
Sally Barrington
No Relationships to Disclose
 
Peter W. M. Johnson
Honoraria - Epizyme; InCyte
Consulting or Advisory Role - Epizyme
Patents, Royalties, Other Intellectual Property - Combined use of Fc gamma RIIb (CD32b) and CD20 - specific antibodies. WO Patent, PCT/GB2011/051572; EU11760819.0
 
Maurizio Martelli
Honoraria - BeiGene; Bristol-Myers Squibb; EUSA Pharma; Gilead Sciences; Incyte; Novartis; Roche
Consulting or Advisory Role - BeiGene; EUSA Pharma; Gilead Sciences; Incyte; Novartis; Roche
Speakers' Bureau - BeiGene; EUSA Pharma; Gilead Sciences; Incyte; Novartis; Roche
Travel, Accommodations, Expenses - Roche